Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$23.91 - $31.3 $1.91 Million - $2.5 Million
80,000 Added 400.0%
100,000 $2.55 Million
Q2 2024

Aug 14, 2024

BUY
$23.0 - $31.04 $460,000 - $620,800
20,000 New
20,000 $506,000
Q4 2023

Feb 14, 2024

BUY
$24.02 - $43.89 $600,500 - $1.1 Million
25,000 New
25,000 $1.01 Million
Q2 2023

Aug 14, 2023

BUY
$13.29 - $18.01 $71,766 - $97,254
5,400 New
5,400 $92,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.52B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.